This track will explore the latest advancements in the diagnosis and treatment of acute coronary syndrome. Emphasis will be placed on novel therapeutic strategies and their clinical implications.

This session focuses on the complexities of managing adult patients with congenital heart disease. Discussions will include multidisciplinary approaches and emerging treatment modalities.

This track will delve into recent developments in cardiac electrophysiology, including innovative techniques for arrhythmia management. Participants will examine the role of technology in improving patient outcomes.

This session aims to provide insights into the latest research and clinical practices surrounding atrial fibrillation. Topics will include risk stratification, management strategies, and patient education.

This track will investigate the connections between cerebrovascular disorders and cardiac health. Presentations will highlight the shared risk factors and implications for integrated care.

This session will cover the underlying mechanisms of coronary artery disease and the latest therapeutic approaches. Emphasis will be placed on both pharmacological and interventional strategies.

This track will focus on the latest surgical techniques and innovations in cardiac surgery. Discussions will include minimally invasive approaches and their impact on patient recovery.

This session will review the latest developments in cardiac pharmaceutical agents, focusing on their efficacy and safety profiles. Participants will discuss the implications for clinical practice and patient management.

This track will address the complexities of diagnosing and managing congenital heart defects. Emphasis will be placed on the latest research and best practices in patient care.

This session will explore the fundamental principles of cardiac physiology and their relevance to clinical practice. Discussions will include the impact of physiological changes on cardiovascular health.

This track will examine the latest research and treatment options for valvular heart disease. Emphasis will be placed on surgical and non-surgical interventions and their outcomes.